Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy
- PMID: 20394536
- DOI: 10.2217/nnm.10.9
Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy
Erratum in
- Nanomedicine (Lond). 2010 Jun;5(4):676
Abstract
Aim: To develop a suitable formulation of curcumin-encapsulated methoxy poly(ethylene glycol) (MePEG)/poly-epsilon-caprolactone (PCL) diblock copolymeric micelle by varying the copolymer ratio, for achieving small sized micelles with high encapsulation of curcumin. To evaluate the micelle's aqueous solubility and stability, efficiency of cellular uptake, cell cytotoxicity and ability to induce apoptosis on pancreatic cell lines.
Method: Amphiphilic diblock copolymers (composed of MePEG and PCL) were used in various ratios for the preparation of curcumin-encapsulated micelles using a modified dialysis method. Physicochemical characterization of the formulation included size and surface charge measurement, transmission electron microscopy characterization, spectroscopic analysis, stability and in vitro release kinetics studies. The anticancer efficacy of the curcumin-encapsulated micelle formulation was compared with unmodified curcumin in terms of cellular uptake, cell cytotoxicity and apoptosis of pancreatic cell lines MIA PaCa-2 and PANC-1.
Results: Physiochemical characterization of the formulations revealed that curcumin was efficiently encapsulated in all formulation of MePEG/PCL micelles; however, a 40:60 MePEG:PCL ratio micelle was chosen for experimental studies owing to its high encapsulation (approximately 60%) with size (approximately 110 nm) and negative zeta potential (approximately -16 mV). Curcumin-encapsulated micelles increased the bioavailability of curcumin due to enhanced uptake (2.95 times more compared with unmodified) with comparative cytotoxic activity (by induction of apoptosis) compared with unmodified curcumin at equimolar concentrations. IC(50) values for unmodified curcumin and curcumin micelles were found to be 24.75 microM and 22.8 microM for PANC-1 and 14.96 microM and 13.85 microM for MIA PaCa-2, respectively. Together the results clearly indicate the promise of a micellar system for efficient solubilization, stabilization and controlled delivery of the hydrophobic drug curcumin for cancer therapy.
Similar articles
-
Etoposide-loaded biodegradable amphiphilic methoxy (poly ethylene glycol) and poly (epsilon caprolactone) copolymeric micelles as drug delivery vehicle for cancer therapy.Drug Deliv. 2010 Jul;17(5):330-42. doi: 10.3109/10717541003720688. Drug Deliv. 2010. PMID: 20370380
-
Linear-dendrimer type methoxy-poly (ethylene glycol)-b-poly (ε-caprolactone) copolymer micelles for the delivery of curcumin.Drug Deliv. 2015 Jan;22(1):58-68. doi: 10.3109/10717544.2014.901436. Epub 2014 Apr 14. Drug Deliv. 2015. PMID: 24725028
-
Y-shaped Folic Acid-Conjugated PEG-PCL Copolymeric Micelles for Delivery of Curcumin.Anticancer Agents Med Chem. 2017;17(4):599-607. doi: 10.2174/1871520616666160815124014. Anticancer Agents Med Chem. 2017. PMID: 27528180
-
Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations.Adv Drug Deliv Rev. 2002 Feb 21;54(2):191-202. doi: 10.1016/s0169-409x(02)00016-9. Adv Drug Deliv Rev. 2002. PMID: 11897145 Review.
-
Conundrum and therapeutic potential of curcumin in drug delivery.Crit Rev Ther Drug Carrier Syst. 2010;27(4):279-312. doi: 10.1615/critrevtherdrugcarriersyst.v27.i4.10. Crit Rev Ther Drug Carrier Syst. 2010. PMID: 20932240 Review.
Cited by
-
Curcumin Delivery by Poly(Lactide)-Based Co-Polymeric Micelles: An In Vitro Anticancer Study.Pharm Res. 2016 Apr;33(4):826-41. doi: 10.1007/s11095-015-1830-z. Epub 2015 Nov 23. Pharm Res. 2016. PMID: 26597940
-
Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.Biomolecules. 2021 Mar 7;11(3):392. doi: 10.3390/biom11030392. Biomolecules. 2021. PMID: 33800000 Free PMC article. Review.
-
Impact of nanotechnology in cancer: emphasis on nanochemoprevention.Int J Nanomedicine. 2012;7:591-605. doi: 10.2147/IJN.S26026. Epub 2012 Feb 2. Int J Nanomedicine. 2012. PMID: 22346353 Free PMC article. Review.
-
Renewable poly(δ-decalactone) based block copolymer micelles as drug delivery vehicle: in vitro and in vivo evaluation.Saudi Pharm J. 2018 Mar;26(3):358-368. doi: 10.1016/j.jsps.2018.01.006. Epub 2018 Feb 1. Saudi Pharm J. 2018. PMID: 29556127 Free PMC article.
-
Milk/colostrum exosomes: A nanoplatform advancing delivery of cancer therapeutics.Cancer Lett. 2023 May 1;561:216141. doi: 10.1016/j.canlet.2023.216141. Epub 2023 Mar 22. Cancer Lett. 2023. PMID: 36963459 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical